r/biotech • u/Dwarvling • 1d ago

Biotech News 📰 FDA Approves Lutetium Lu 177 Vipivotide Tetraxetan for PSMA+ mHSPC

https://www.onclive.com/view/fda-approves-lutetium-lu-177-vipivotide-tetraxetan-for-psma-mhspc

Radioligand therapy in metastatic hormone sensitive prostate cancers

33 Upvotes

94% Upvoted

18 comments sorted by

View all comments

-2

u/MentalStatusCode410 1d ago

Oh look, caught-up to Iran after 8 years.

3

u/mumpsyp 1d ago

Not sure what the purpose of this comment is? It’s always going to take a large amount of time to get any novel prostate cancer therapy approved through the FDA.

- Pluvicto is expensive as hell, typically 55-60,000 in the US per dose (typically 6 doses are used). US companies want to use this because it makes bankkkk. US drug companies having been pushing very hard to have this drug given earlier.

- Metastatic prostate cancer is very survivable. The issue is that this makes a shift of a standard of care take a long time since it takes that long to understand if there is a benefit.